Comparison of postoperative nausea and vomiting between Remimazolam and Propofol in Patients undergoing oral and maxillofacial surgery: a prospective Randomized Controlled Trial

BACKGROUND: Remimazolam is a recently approved, ultra-short-acting benzodiazepine. However, few studies have investigated remimazolam in relation to postoperative nausea and vomiting (PONV). This study aimed to compare the effects of remimazolam and propofol on PONV in patients undergoing oral and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eun-Jung, Kim, Cheul-Hong, Yoon, Ji-Young, Byeon, Gyeong-Jo, Kim, Hee Young, Choi, Eun-Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122311/
https://www.ncbi.nlm.nih.gov/pubmed/37085760
http://dx.doi.org/10.1186/s12871-023-02091-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122311/
https://www.ncbi.nlm.nih.gov/pubmed/37085760
http://dx.doi.org/10.1186/s12871-023-02091-3

Ejemplares similares